TWI494101B - 包含迷迭香酸之組合物的改良生物效應 - Google Patents
包含迷迭香酸之組合物的改良生物效應 Download PDFInfo
- Publication number
- TWI494101B TWI494101B TW096141951A TW96141951A TWI494101B TW I494101 B TWI494101 B TW I494101B TW 096141951 A TW096141951 A TW 096141951A TW 96141951 A TW96141951 A TW 96141951A TW I494101 B TWI494101 B TW I494101B
- Authority
- TW
- Taiwan
- Prior art keywords
- composition
- hydrolase
- rosmarinic acid
- food
- products
- Prior art date
Links
- DOUMFZQKYFQNTF-WUTVXBCWSA-N (R)-rosmarinic acid Chemical compound C([C@H](C(=O)O)OC(=O)\C=C\C=1C=C(O)C(O)=CC=1)C1=CC=C(O)C(O)=C1 DOUMFZQKYFQNTF-WUTVXBCWSA-N 0.000 title claims description 193
- 239000000203 mixture Substances 0.000 title claims description 139
- ZZAFFYPNLYCDEP-HNNXBMFYSA-N Rosmarinsaeure Natural products OC(=O)[C@H](Cc1cccc(O)c1O)OC(=O)C=Cc2ccc(O)c(O)c2 ZZAFFYPNLYCDEP-HNNXBMFYSA-N 0.000 title claims description 96
- DOUMFZQKYFQNTF-MRXNPFEDSA-N rosemarinic acid Natural products C([C@H](C(=O)O)OC(=O)C=CC=1C=C(O)C(O)=CC=1)C1=CC=C(O)C(O)=C1 DOUMFZQKYFQNTF-MRXNPFEDSA-N 0.000 title claims description 96
- TVHVQJFBWRLYOD-UHFFFAOYSA-N rosmarinic acid Natural products OC(=O)C(Cc1ccc(O)c(O)c1)OC(=Cc2ccc(O)c(O)c2)C=O TVHVQJFBWRLYOD-UHFFFAOYSA-N 0.000 title claims description 96
- 230000004071 biological effect Effects 0.000 title claims description 16
- QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 claims description 40
- 244000005700 microbiome Species 0.000 claims description 39
- 239000000047 product Substances 0.000 claims description 39
- 102000004157 Hydrolases Human genes 0.000 claims description 38
- 108090000604 Hydrolases Proteins 0.000 claims description 38
- 235000013305 food Nutrition 0.000 claims description 33
- 102000004190 Enzymes Human genes 0.000 claims description 23
- 108090000790 Enzymes Proteins 0.000 claims description 23
- ACEAELOMUCBPJP-UHFFFAOYSA-N (E)-3,4,5-trihydroxycinnamic acid Natural products OC(=O)C=CC1=CC(O)=C(O)C(O)=C1 ACEAELOMUCBPJP-UHFFFAOYSA-N 0.000 claims description 20
- 235000004883 caffeic acid Nutrition 0.000 claims description 20
- 229940074360 caffeic acid Drugs 0.000 claims description 20
- QAIPRVGONGVQAS-UHFFFAOYSA-N cis-caffeic acid Natural products OC(=O)C=CC1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-UHFFFAOYSA-N 0.000 claims description 20
- 239000007788 liquid Substances 0.000 claims description 20
- 238000000034 method Methods 0.000 claims description 20
- 230000000699 topical effect Effects 0.000 claims description 19
- 239000006041 probiotic Substances 0.000 claims description 18
- 235000018291 probiotics Nutrition 0.000 claims description 18
- 239000000243 solution Substances 0.000 claims description 18
- LWGJTAZLEJHCPA-UHFFFAOYSA-N n-(2-chloroethyl)-n-nitrosomorpholine-4-carboxamide Chemical compound ClCCN(N=O)C(=O)N1CCOCC1 LWGJTAZLEJHCPA-UHFFFAOYSA-N 0.000 claims description 16
- 230000000529 probiotic effect Effects 0.000 claims description 16
- 239000006185 dispersion Substances 0.000 claims description 15
- 239000006210 lotion Substances 0.000 claims description 15
- 235000013336 milk Nutrition 0.000 claims description 15
- 239000008267 milk Substances 0.000 claims description 15
- 210000004080 milk Anatomy 0.000 claims description 15
- 230000007062 hydrolysis Effects 0.000 claims description 14
- 238000006460 hydrolysis reaction Methods 0.000 claims description 14
- 235000016709 nutrition Nutrition 0.000 claims description 13
- 239000000843 powder Substances 0.000 claims description 13
- PAFLSMZLRSPALU-UHFFFAOYSA-N 3-(3,4-dihydroxyphenyl)lactic acid Chemical compound OC(=O)C(O)CC1=CC=C(O)C(O)=C1 PAFLSMZLRSPALU-UHFFFAOYSA-N 0.000 claims description 12
- PAFLSMZLRSPALU-QMMMGPOBSA-N Danshensu Natural products OC(=O)[C@@H](O)CC1=CC=C(O)C(O)=C1 PAFLSMZLRSPALU-QMMMGPOBSA-N 0.000 claims description 12
- 239000012071 phase Substances 0.000 claims description 12
- 241001468157 Lactobacillus johnsonii Species 0.000 claims description 10
- 239000006071 cream Substances 0.000 claims description 10
- 239000000839 emulsion Substances 0.000 claims description 10
- 239000007787 solid Substances 0.000 claims description 10
- 239000000725 suspension Substances 0.000 claims description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- 239000002537 cosmetic Substances 0.000 claims description 9
- 230000006378 damage Effects 0.000 claims description 9
- 241000901050 Bifidobacterium animalis subsp. lactis Species 0.000 claims description 8
- 239000008346 aqueous phase Substances 0.000 claims description 8
- 229940009289 bifidobacterium lactis Drugs 0.000 claims description 8
- 239000002775 capsule Substances 0.000 claims description 8
- 235000015872 dietary supplement Nutrition 0.000 claims description 8
- 239000000419 plant extract Substances 0.000 claims description 8
- 235000013339 cereals Nutrition 0.000 claims description 7
- 238000004519 manufacturing process Methods 0.000 claims description 7
- 230000035764 nutrition Effects 0.000 claims description 7
- 241001608472 Bifidobacterium longum Species 0.000 claims description 6
- 108090000371 Esterases Proteins 0.000 claims description 6
- 235000010469 Glycine max Nutrition 0.000 claims description 6
- 235000010676 Ocimum basilicum Nutrition 0.000 claims description 6
- 240000002657 Thymus vulgaris Species 0.000 claims description 6
- 235000007303 Thymus vulgaris Nutrition 0.000 claims description 6
- 235000013361 beverage Nutrition 0.000 claims description 6
- 229940009291 bifidobacterium longum Drugs 0.000 claims description 6
- 235000015140 cultured milk Nutrition 0.000 claims description 6
- 230000003301 hydrolyzing effect Effects 0.000 claims description 6
- 238000001727 in vivo Methods 0.000 claims description 6
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 6
- 239000007937 lozenge Substances 0.000 claims description 6
- 239000011707 mineral Substances 0.000 claims description 6
- 235000013618 yogurt Nutrition 0.000 claims description 6
- 102000002274 Matrix Metalloproteinases Human genes 0.000 claims description 5
- 108010000684 Matrix Metalloproteinases Proteins 0.000 claims description 5
- 244000124853 Perilla frutescens Species 0.000 claims description 5
- 230000001580 bacterial effect Effects 0.000 claims description 5
- 235000009508 confectionery Nutrition 0.000 claims description 5
- 235000015243 ice cream Nutrition 0.000 claims description 5
- 239000004615 ingredient Substances 0.000 claims description 5
- 239000004530 micro-emulsion Substances 0.000 claims description 5
- 239000003094 microcapsule Substances 0.000 claims description 5
- 239000011859 microparticle Substances 0.000 claims description 5
- 239000002002 slurry Substances 0.000 claims description 5
- 239000007921 spray Substances 0.000 claims description 5
- 239000001585 thymus vulgaris Substances 0.000 claims description 5
- 240000006054 Agastache cana Species 0.000 claims description 4
- 235000010650 Hyssopus officinalis Nutrition 0.000 claims description 4
- 235000013628 Lantana involucrata Nutrition 0.000 claims description 4
- 244000178870 Lavandula angustifolia Species 0.000 claims description 4
- 235000010663 Lavandula angustifolia Nutrition 0.000 claims description 4
- 244000062730 Melissa officinalis Species 0.000 claims description 4
- 235000010654 Melissa officinalis Nutrition 0.000 claims description 4
- 244000246386 Mentha pulegium Species 0.000 claims description 4
- 235000016257 Mentha pulegium Nutrition 0.000 claims description 4
- 235000004357 Mentha x piperita Nutrition 0.000 claims description 4
- 235000006677 Monarda citriodora ssp. austromontana Nutrition 0.000 claims description 4
- 235000004347 Perilla Nutrition 0.000 claims description 4
- 240000009164 Petroselinum crispum Species 0.000 claims description 4
- 235000019219 chocolate Nutrition 0.000 claims description 4
- 235000016213 coffee Nutrition 0.000 claims description 4
- 235000013353 coffee beverage Nutrition 0.000 claims description 4
- 238000010411 cooking Methods 0.000 claims description 4
- 235000001050 hortel pimenta Nutrition 0.000 claims description 4
- 235000008960 ketchup Nutrition 0.000 claims description 4
- 239000001102 lavandula vera Substances 0.000 claims description 4
- 235000018219 lavender Nutrition 0.000 claims description 4
- 239000008268 mayonnaise Substances 0.000 claims description 4
- 235000010746 mayonnaise Nutrition 0.000 claims description 4
- 235000010755 mineral Nutrition 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 4
- 235000011197 perejil Nutrition 0.000 claims description 4
- 235000002020 sage Nutrition 0.000 claims description 4
- 235000014438 salad dressings Nutrition 0.000 claims description 4
- 235000014347 soups Nutrition 0.000 claims description 4
- 235000005865 Symphytum officinale Nutrition 0.000 claims description 3
- 240000002299 Symphytum officinale Species 0.000 claims description 3
- 239000003814 drug Substances 0.000 claims description 3
- 239000000835 fiber Substances 0.000 claims description 3
- 235000008216 herbs Nutrition 0.000 claims description 3
- 239000000413 hydrolysate Substances 0.000 claims description 3
- 230000002401 inhibitory effect Effects 0.000 claims description 3
- 150000002632 lipids Chemical class 0.000 claims description 3
- 235000008935 nutritious Nutrition 0.000 claims description 3
- 102000004169 proteins and genes Human genes 0.000 claims description 3
- 108090000623 proteins and genes Proteins 0.000 claims description 3
- 244000178231 Rosmarinus officinalis Species 0.000 claims description 2
- 235000014633 carbohydrates Nutrition 0.000 claims description 2
- 150000001720 carbohydrates Chemical class 0.000 claims description 2
- 239000003205 fragrance Substances 0.000 claims description 2
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 2
- 239000011782 vitamin Substances 0.000 claims description 2
- 235000013343 vitamin Nutrition 0.000 claims description 2
- 229940088594 vitamin Drugs 0.000 claims description 2
- 229930003231 vitamin Natural products 0.000 claims description 2
- 235000011868 grain product Nutrition 0.000 claims 2
- 241000186000 Bifidobacterium Species 0.000 claims 1
- 240000007926 Ocimum gratissimum Species 0.000 claims 1
- 235000011203 Origanum Nutrition 0.000 claims 1
- 240000000783 Origanum majorana Species 0.000 claims 1
- 240000007673 Origanum vulgare Species 0.000 claims 1
- 238000009833 condensation Methods 0.000 claims 1
- 230000005494 condensation Effects 0.000 claims 1
- 239000000865 liniment Substances 0.000 claims 1
- 229940088598 enzyme Drugs 0.000 description 22
- 230000000694 effects Effects 0.000 description 17
- 210000004027 cell Anatomy 0.000 description 12
- 238000006243 chemical reaction Methods 0.000 description 9
- 102000000380 Matrix Metalloproteinase 1 Human genes 0.000 description 8
- 239000000284 extract Substances 0.000 description 8
- 241000894006 Bacteria Species 0.000 description 7
- 108010016113 Matrix Metalloproteinase 1 Proteins 0.000 description 6
- 241001529742 Rosmarinus Species 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 6
- 239000000499 gel Substances 0.000 description 6
- 238000011534 incubation Methods 0.000 description 6
- 239000002609 medium Substances 0.000 description 6
- 239000000758 substrate Substances 0.000 description 6
- 244000180308 Ocimum basilicum Species 0.000 description 5
- 238000002965 ELISA Methods 0.000 description 4
- 241000233866 Fungi Species 0.000 description 4
- 101001013150 Homo sapiens Interstitial collagenase Proteins 0.000 description 4
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 4
- 238000005119 centrifugation Methods 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 239000001296 salvia officinalis l. Substances 0.000 description 4
- 239000012064 sodium phosphate buffer Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 238000011282 treatment Methods 0.000 description 4
- 230000037303 wrinkles Effects 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 3
- 241000208152 Geranium Species 0.000 description 3
- 240000005183 Lantana involucrata Species 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000012594 Earle’s Balanced Salt Solution Substances 0.000 description 2
- 206010021143 Hypoxia Diseases 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- 235000006679 Mentha X verticillata Nutrition 0.000 description 2
- 235000002899 Mentha suaveolens Nutrition 0.000 description 2
- 235000001636 Mentha x rotundifolia Nutrition 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 240000007164 Salvia officinalis Species 0.000 description 2
- 238000005903 acid hydrolysis reaction Methods 0.000 description 2
- 238000000540 analysis of variance Methods 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 235000013351 cheese Nutrition 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 208000002854 epidermolysis bullosa simplex superficialis Diseases 0.000 description 2
- 210000002950 fibroblast Anatomy 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 239000007903 gelatin capsule Substances 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 230000007954 hypoxia Effects 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 150000008442 polyphenolic compounds Chemical class 0.000 description 2
- 235000013824 polyphenols Nutrition 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 230000035484 reaction time Effects 0.000 description 2
- 229940092258 rosemary extract Drugs 0.000 description 2
- 235000020748 rosemary extract Nutrition 0.000 description 2
- 239000001233 rosmarinus officinalis l. extract Substances 0.000 description 2
- 239000000344 soap Substances 0.000 description 2
- 230000035882 stress Effects 0.000 description 2
- 230000000475 sunscreen effect Effects 0.000 description 2
- 239000000516 sunscreening agent Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- -1 troches Substances 0.000 description 2
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 1
- JVGVDSSUAVXRDY-UHFFFAOYSA-N 3-(4-hydroxyphenyl)lactic acid Chemical compound OC(=O)C(O)CC1=CC=C(O)C=C1 JVGVDSSUAVXRDY-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 208000028185 Angioedema Diseases 0.000 description 1
- 206010004146 Basal cell carcinoma Diseases 0.000 description 1
- 241000167854 Bourreria succulenta Species 0.000 description 1
- 208000014644 Brain disease Diseases 0.000 description 1
- 241000195940 Bryophyta Species 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 241000296607 Celastrus hindsii Species 0.000 description 1
- 241000296615 Celastrus strigillosus Species 0.000 description 1
- 208000002881 Colic Diseases 0.000 description 1
- 102000029816 Collagenase Human genes 0.000 description 1
- 108060005980 Collagenase Proteins 0.000 description 1
- 230000033616 DNA repair Effects 0.000 description 1
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- 206010014970 Ephelides Diseases 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- CITFYDYEWQIEPX-UHFFFAOYSA-N Flavanol Natural products O1C2=CC(OCC=C(C)C)=CC(O)=C2C(=O)C(O)C1C1=CC=C(O)C=C1 CITFYDYEWQIEPX-UHFFFAOYSA-N 0.000 description 1
- 206010062016 Immunosuppression Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 102000015696 Interleukins Human genes 0.000 description 1
- 108010063738 Interleukins Proteins 0.000 description 1
- 102000004317 Lyases Human genes 0.000 description 1
- 108090000856 Lyases Proteins 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 235000014435 Mentha Nutrition 0.000 description 1
- 241001072983 Mentha Species 0.000 description 1
- 235000004348 Perilla frutescens Nutrition 0.000 description 1
- 208000012641 Pigmentation disease Diseases 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 206010037549 Purpura Diseases 0.000 description 1
- 241001672981 Purpura Species 0.000 description 1
- 235000017276 Salvia Nutrition 0.000 description 1
- 235000002912 Salvia officinalis Nutrition 0.000 description 1
- 206010039796 Seborrhoeic keratosis Diseases 0.000 description 1
- 206010043189 Telangiectasia Diseases 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 208000033676 Venous lake Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 208000009621 actinic keratosis Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 238000009098 adjuvant therapy Methods 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000002220 antihypertensive agent Substances 0.000 description 1
- 229940030600 antihypertensive agent Drugs 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 208000003373 basosquamous carcinoma Diseases 0.000 description 1
- 238000003287 bathing Methods 0.000 description 1
- 235000015496 breakfast cereal Nutrition 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 235000019693 cherries Nutrition 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 229960002424 collagenase Drugs 0.000 description 1
- 238000004737 colorimetric analysis Methods 0.000 description 1
- 239000012228 culture supernatant Substances 0.000 description 1
- 208000030381 cutaneous melanoma Diseases 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 230000003412 degenerative effect Effects 0.000 description 1
- 239000002781 deodorant agent Substances 0.000 description 1
- 230000002951 depilatory effect Effects 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 210000004177 elastic tissue Anatomy 0.000 description 1
- 230000007071 enzymatic hydrolysis Effects 0.000 description 1
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 description 1
- 230000036566 epidermal hyperplasia Effects 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000003804 extraction from natural source Methods 0.000 description 1
- 235000001785 ferulic acid Nutrition 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 1
- 229940114124 ferulic acid Drugs 0.000 description 1
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 1
- 150000002206 flavan-3-ols Chemical class 0.000 description 1
- 235000011987 flavanols Nutrition 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 235000002864 food coloring agent Nutrition 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000013350 formula milk Nutrition 0.000 description 1
- 230000000855 fungicidal effect Effects 0.000 description 1
- 239000000417 fungicide Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 239000007902 hard capsule Substances 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 208000000069 hyperpigmentation Diseases 0.000 description 1
- 230000003810 hyperpigmentation Effects 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 230000001506 immunosuppresive effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 201000001441 melanoma Diseases 0.000 description 1
- 235000011929 mousse Nutrition 0.000 description 1
- 239000006872 mrs medium Substances 0.000 description 1
- 239000002417 nutraceutical Substances 0.000 description 1
- 235000021436 nutraceutical agent Nutrition 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 238000011533 pre-incubation Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000000197 pyrolysis Methods 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 244000081595 rats tail grass Species 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 235000015639 rosmarinus officinalis Nutrition 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 210000001732 sebaceous gland Anatomy 0.000 description 1
- 201000003385 seborrheic keratosis Diseases 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 231100000075 skin burn Toxicity 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 208000009056 telangiectasis Diseases 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 1
- 230000036572 transepidermal water loss Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L31/00—Edible extracts or preparations of fungi; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/14—Yeasts or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L31/00—Edible extracts or preparations of fungi; Preparation or treatment thereof
- A23L31/10—Yeasts or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Molecular Biology (AREA)
- Botany (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Emergency Medicine (AREA)
- Biotechnology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dermatology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cosmetics (AREA)
- Enzymes And Modification Thereof (AREA)
- Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP06023060A EP1917960A1 (fr) | 2006-11-06 | 2006-11-06 | Effects biologiques améliorée de l'acide rosmarinique |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TW200829233A TW200829233A (en) | 2008-07-16 |
| TWI494101B true TWI494101B (zh) | 2015-08-01 |
Family
ID=37814047
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW096141951A TWI494101B (zh) | 2006-11-06 | 2007-11-06 | 包含迷迭香酸之組合物的改良生物效應 |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US8932579B2 (fr) |
| EP (2) | EP1917960A1 (fr) |
| CN (1) | CN101563078B (fr) |
| AR (1) | AR063570A1 (fr) |
| AT (1) | ATE461699T1 (fr) |
| AU (1) | AU2007316954B2 (fr) |
| BR (1) | BRPI0718533B8 (fr) |
| CA (1) | CA2668472C (fr) |
| CL (1) | CL2007003203A1 (fr) |
| DE (1) | DE602007005506D1 (fr) |
| ES (1) | ES2344127T3 (fr) |
| MX (1) | MX2009004739A (fr) |
| TW (1) | TWI494101B (fr) |
| WO (1) | WO2008055651A1 (fr) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105475990A (zh) * | 2015-11-30 | 2016-04-13 | 杭州鑫伟低碳技术研发有限公司 | 一种灵芝孢子粉或灵芝多糖悬浮凝胶的制造方法 |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2210504A1 (fr) * | 2009-01-27 | 2010-07-28 | Nestec S.A. | Composition comportant de l'acide chicorique et/ou dérivés associés |
| EP2734049B1 (fr) | 2011-06-20 | 2018-05-02 | H.J. Heinz Company Brands LLC | Méthodes et compositions probiotiques |
| WO2013190068A1 (fr) * | 2012-06-22 | 2013-12-27 | Nestec S.A. | Probiotique et polyphénol contre la neurodégénérescence |
| WO2014044591A1 (fr) * | 2012-09-21 | 2014-03-27 | Nestec S.A. | Composition comprenant des phénols végétaux pour la prévention ou la réduction de la perte d'eau transépidermique et de troubles et maladies associés |
| ES2795104T3 (es) * | 2012-09-21 | 2020-11-20 | Nestle Sa | Fenoles vegetales y su uso en el tratamiento o la prevención de la esofagitis eosinofílica |
| CN103083207A (zh) * | 2013-01-18 | 2013-05-08 | 吉林农业大学 | 皮肤营养护理液 |
| EP3091851A1 (fr) * | 2013-12-20 | 2016-11-16 | Abbott Laboratories | Composition nutritionnelle contenant de l'huile oxydable et de l'acide rosmarinique |
| RU2552790C1 (ru) * | 2014-01-13 | 2015-06-10 | Федеральное государственное бюджетное учреждение науки Институт биологии Коми научного центра Уральского отделения Российской академии наук | Противоожоговая композиция |
| US9307860B2 (en) | 2014-02-14 | 2016-04-12 | Remington Designs, Llc | Processor control of solute extraction system |
| RU2017101522A (ru) * | 2014-06-19 | 2018-07-19 | Кемин Индастриз, Инк. | Ингредиенты для отсроченного окисления молочного жира |
| SG11201702834WA (en) * | 2014-10-08 | 2017-05-30 | Abbott Lab | Nutritional compositions comprising an oxidizable component and water-soluble plant extract |
| AU2015362091B2 (en) * | 2014-12-11 | 2020-11-26 | Saluda Medical Pty Ltd | Method and device for feedback control of neural stimulation |
| CN106360727B (zh) * | 2016-11-22 | 2023-06-27 | 江南大学 | 一种植物的综合利用方法 |
| CN106578403B (zh) * | 2016-12-07 | 2020-12-01 | 江南大学 | 紫苏籽粕的综合利用方法 |
| DK3780975T3 (da) * | 2018-04-17 | 2022-10-31 | Protea Biopharma N V | Sammensætning som sikrer beskyttelse mod frie radikaler og tilvejebringer vedvarende frigivelse af energi |
| KR102040972B1 (ko) * | 2018-09-14 | 2019-11-05 | 마이크로바이오주식회사 | 피부 노화 방지 또는 주름 개선 활성이 있는 신규한 비피도박테리움 락티스(Bifidobacterium lactis) UBC-U04 및 이를 이용한 조성물 |
| CN110172493A (zh) * | 2019-05-28 | 2019-08-27 | 湖南中医药大学 | 一种咖啡酸的制备方法 |
| CN114288333B (zh) * | 2021-12-28 | 2022-10-21 | 中国科学院植物研究所 | 一种抑制皮肤黑素瘤细胞增殖的迷迭香复方精油及其用途 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69219768T2 (de) | 1992-07-06 | 1997-08-28 | Societe Des Produits Nestle S.A., Vevey | Milchbakterien |
| US6245363B1 (en) | 1995-06-07 | 2001-06-12 | Zylepsis Limited | Methods of treating plant materials with hydrolytic enzymes isolated from humicola species |
| FR2755368B1 (fr) * | 1996-11-04 | 1999-03-19 | Oreal | Composition rincable pour le soin de la peau |
| FR2788435B1 (fr) * | 1999-01-15 | 2002-08-02 | Oreal | Utilisation d'un extrait d'un vegetal du genre rosmarinus dans des compositions destinees a traiter les signes cutanes du vieillissement |
| EP1110555A1 (fr) * | 1999-12-22 | 2001-06-27 | Societe Des Produits Nestle S.A. | Agent anti-adhesion de la flore pathogene de la peau |
| EP1151673A3 (fr) | 2000-05-03 | 2002-01-02 | Societe Des Produits Nestle S.A. | Confiserié avec remplissage |
| AU2002222747A1 (en) * | 2000-12-12 | 2002-06-24 | Angiolab, Inc. | Composition comprising melissa leaf extract for anti-angiogenic and matrix metalloproteinase inhibitory activity |
| KR20030082764A (ko) * | 2002-04-18 | 2003-10-23 | 에스케이케미칼주식회사 | 관절조직 보호 작용을 갖는 생약조성물 |
| AU2003284985A1 (en) * | 2002-10-23 | 2004-05-13 | Rutgers, The State University Of New Jersey | Production of vanillin in microbial cells |
| FR2848851B1 (fr) * | 2002-12-20 | 2006-03-10 | Procede d'obtention d'un principe actif presentant des capacites apaisantes, principe actif et compositions obtenues | |
| US20050037094A1 (en) * | 2003-07-31 | 2005-02-17 | Xijun Yan | Composition for heart disease, its active ingredients, method to prepare same and uses thereof |
| EP1604647B1 (fr) * | 2004-05-12 | 2008-05-07 | Chisso Corporation | Composition cosmétique comprenant un polymère à base de polyorganosiloxane et d' epsilon-polylysine, ainsi qu'un polyol, et sa fabrication |
| US20060269508A1 (en) * | 2005-03-29 | 2006-11-30 | Trejo Amy V | Means for regulating the cosmetic appearance and/or health of human keratinous tissue |
| EP2210504A1 (fr) * | 2009-01-27 | 2010-07-28 | Nestec S.A. | Composition comportant de l'acide chicorique et/ou dérivés associés |
-
2006
- 2006-11-06 EP EP06023060A patent/EP1917960A1/fr not_active Withdrawn
-
2007
- 2007-11-05 AR ARP070104924A patent/AR063570A1/es active IP Right Grant
- 2007-11-06 TW TW096141951A patent/TWI494101B/zh not_active IP Right Cessation
- 2007-11-06 WO PCT/EP2007/009602 patent/WO2008055651A1/fr active Application Filing
- 2007-11-06 CL CL200703203A patent/CL2007003203A1/es unknown
- 2007-11-06 CN CN200780040651.1A patent/CN101563078B/zh not_active Expired - Fee Related
- 2007-11-06 AT AT07819621T patent/ATE461699T1/de not_active IP Right Cessation
- 2007-11-06 EP EP07819621A patent/EP2081566B1/fr not_active Not-in-force
- 2007-11-06 CA CA2668472A patent/CA2668472C/fr not_active Expired - Fee Related
- 2007-11-06 AU AU2007316954A patent/AU2007316954B2/en not_active Ceased
- 2007-11-06 ES ES07819621T patent/ES2344127T3/es active Active
- 2007-11-06 DE DE602007005506T patent/DE602007005506D1/de active Active
- 2007-11-06 BR BRPI0718533A patent/BRPI0718533B8/pt not_active IP Right Cessation
- 2007-11-06 US US12/513,631 patent/US8932579B2/en not_active Expired - Fee Related
- 2007-11-06 MX MX2009004739A patent/MX2009004739A/es active IP Right Grant
-
2013
- 2013-09-18 US US14/030,611 patent/US9314490B2/en not_active Expired - Fee Related
Non-Patent Citations (2)
| Title |
|---|
| Del Baño MJ, Castillo J, Benavente-García O, Lorente J, Martín-Gil R, Acevedo C, Alcaraz M., Radioprotective-antimutagenic effects of rosemary phenolics against chromosomal damage induced in human lymphocytes by gamma-rays., J Agric Food Chem. 2006 Mar 22 54(6):2064-8 * |
| Petersen M, Simmonds MS.: Rosmarinic acid, Phytochemistry. 2003 Jan;62(2):121-5 Konishi Y, Kobayashi S.: Transepithelial transport of rosmarinic acid in intestinal Caco-2 cell monolayers, Biosci Biotechnol Biochem. 2005 Mar;69(3):583-91 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105475990A (zh) * | 2015-11-30 | 2016-04-13 | 杭州鑫伟低碳技术研发有限公司 | 一种灵芝孢子粉或灵芝多糖悬浮凝胶的制造方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| AR063570A1 (es) | 2009-02-04 |
| CN101563078B (zh) | 2015-01-21 |
| EP2081566A1 (fr) | 2009-07-29 |
| AU2007316954A1 (en) | 2008-05-15 |
| US9314490B2 (en) | 2016-04-19 |
| CA2668472A1 (fr) | 2008-05-15 |
| BRPI0718533B1 (pt) | 2020-08-18 |
| AU2007316954B2 (en) | 2013-04-18 |
| BRPI0718533A2 (pt) | 2013-11-26 |
| EP1917960A1 (fr) | 2008-05-07 |
| WO2008055651A1 (fr) | 2008-05-15 |
| TW200829233A (en) | 2008-07-16 |
| CL2007003203A1 (es) | 2008-07-04 |
| DE602007005506D1 (de) | 2010-05-06 |
| MX2009004739A (es) | 2009-07-17 |
| BRPI0718533B8 (pt) | 2021-05-25 |
| CN101563078A (zh) | 2009-10-21 |
| CA2668472C (fr) | 2015-04-07 |
| EP2081566B1 (fr) | 2010-03-24 |
| US20100129324A1 (en) | 2010-05-27 |
| US20140023625A1 (en) | 2014-01-23 |
| ATE461699T1 (de) | 2010-04-15 |
| US8932579B2 (en) | 2015-01-13 |
| ES2344127T3 (es) | 2010-08-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI494101B (zh) | 包含迷迭香酸之組合物的改良生物效應 | |
| EP2332520B1 (fr) | Lactobacillus paracasei pour traiter des tâches de sénescence et /ou mélasma | |
| TWI438002B (zh) | Type I Collagen Production Promote Oral Agent | |
| JP5954828B2 (ja) | 皮膚状態の改善用組成物 | |
| US20120294841A1 (en) | Probiotic microorganisms as active agents against changes in the skin's microrelief | |
| JP2008291004A (ja) | 美肌用組成物 | |
| CN101301298A (zh) | 高脂血症预防治疗剂 | |
| CN115025129B (zh) | 含乳酸杆菌的组合物及其预防及/或改善皮肤老化的用途 | |
| TWI794766B (zh) | 含乳酸桿菌之組成物及其預防及/或改善皮膚老化的用途 | |
| CN101306000A (zh) | 睾酮生成及代谢促进剂 | |
| KR20190048564A (ko) | 용암해수를 이용하여 발효한 오메기주의 농축물을 포함하는 피부의 주름개선, 탄력개선 또는 보습용 화장료 조성물 | |
| JP6909569B2 (ja) | 肌質改善剤 | |
| KR101510939B1 (ko) | 밀기울 추출물을 유효성분으로 포함하는 탈모 방지 또는 육모 촉진 조성물 | |
| JP2021155405A (ja) | ５α−レダクターゼ阻害剤 | |
| KR102579105B1 (ko) | 프로바이오틱스를 이용한 수세미오이 추출물의 효소적 전환을 통한 피부미백 개선, 자외선 차단 및 피부암의 예방, 개선 또는 치료용 조성물 | |
| JP2009196895A (ja) | チロシナーゼ阻害剤 | |
| KR20210125932A (ko) | 극저온 초미세분쇄 기술 및 효소화 반응을 이용한 식물분쇄물, 및 이의 용도 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Annulment or lapse of patent due to non-payment of fees |